Adocia Competitors and Similar CompaniesClear all
Adocia's competitors and similar companies include Vericel.
 Adocia Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. |  Vericel Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. | |
Founding Date | Founding Date 2005 | Founding Date 1989 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lyon-3E-Arrondissement, FR HQ | Locations Cambridge, US HQ Ann Arbor, US |
Employees | Employees 75 | Employees 24112% increase |
Valuation ($) | Valuation ($) 158 m | Valuation ($) 2.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) €1.5m (FY, 2025) | Revenue (est.) $276.3m (FY, 2025) |
Cost of goods | Cost of goods €792k (FY, 2025) | Cost of goods $70.7m (FY, 2025) |
Gross profit | Gross profit €3.1m (FY, 2025) | Gross profit $205.6m (FY, 2025) |
Net income | Net income (€16.6m) (FY, 2025) | Net income $16.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Vericel
HQ
Cambridge, US
Employees
241↑ 12% increase
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.
View company